{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:48:09Z","timestamp":1782564489238,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007697","name":"Northern Advancement Center for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007591","name":"Akiyama Life Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007591","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.pan.2021.03.002","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T08:35:01Z","timestamp":1615106101000},"page":"892-902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6994-1840","authenticated-orcid":false,"given":"Hiroki","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-1991","authenticated-orcid":false,"given":"Hidemasa","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5794-7586","authenticated-orcid":false,"given":"Shuhei","family":"Takauji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Sasajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuro","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4321-7774","authenticated-orcid":false,"given":"Mikihiro","family":"Fujiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Sugitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1068-7024","authenticated-orcid":false,"given":"Yusuke","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikatsu","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2021.03.002_bib1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2021.03.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2018.10.013","article-title":"Chemotherapy in elderly patients with pancreatic cancer: efficacy, feasibility and future perspectives","volume":"72","author":"Macchini","year":"2019","journal-title":"Canc Treat Rev"},{"key":"10.1016\/j.pan.2021.03.002_bib3","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1038\/ctg.2017.3","article-title":"Diversity of precursor lesions for pancreatic cancer: the genetics and biology of intraductal papillary mucinous neoplasm","volume":"8","author":"Patra","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.pan.2021.03.002_bib4","first-page":"5501","article-title":"Relationship of carbohydrate antigen 19-9 and lewis antigens in pancreatic cancer","volume":"47","author":"Tempero","year":"1987","journal-title":"Canc Res"},{"key":"10.1016\/j.pan.2021.03.002_bib5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s13277-011-0297-8","article-title":"Ca 19-9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer","volume":"33","author":"Molina","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.pan.2021.03.002_bib6","doi-asserted-by":"crossref","first-page":"E433","DOI":"10.1111\/ans.15379","article-title":"Sarcopenia is an independent predictor of delayed gastric emptying following pancreaticoduodenectomy: a retrospective study","volume":"89","author":"Shintakuya","year":"2019","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.pan.2021.03.002_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12880-019-0332-6","article-title":"Power of computed-tomography-defined sarcopenia for prediction of morbidity after pancreaticoduodenectomy","volume":"19","author":"Linder","year":"2019","journal-title":"BMC Med Imag"},{"key":"10.1016\/j.pan.2021.03.002_bib8","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s00330-018-5790-7","article-title":"Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired ct and mri","volume":"29","author":"Jang","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.pan.2021.03.002_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1083\/jcb.201307066","article-title":"Macrophages in pancreatic cancer: starting things off on the wrong track","volume":"202","author":"Deschenes-Simard","year":"2013","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.pan.2021.03.002_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MPA.0000000000000446","article-title":"Evaluation of modified glasgow prognostic score for pancreatic cancer: a retrospective cohort study","volume":"45","author":"Imaoka","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2021.03.002_bib11","doi-asserted-by":"crossref","first-page":"11026","DOI":"10.1038\/srep11026","article-title":"Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.pan.2021.03.002_bib12","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/jgh.14926","article-title":"Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second-line palliative chemotherapy","volume":"35","author":"Hsu","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2021.03.002_bib13","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/01635581.2016.1250921","article-title":"The significance of the prognostic nutritional index for all stages of pancreatic cancer","volume":"69","author":"Lee","year":"2017","journal-title":"Nutr Canc"},{"key":"10.1016\/j.pan.2021.03.002_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1245\/s10434-016-5668-3","article-title":"Impact of skeletal muscle mass, muscle quality, and visceral adiposity on outcomes following resection of intrahepatic cholangiocarcinoma","volume":"24","author":"Okumura","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pan.2021.03.002_bib15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s11605-016-3146-7","article-title":"Preoperative sarcopenia strongly influences the risk of postoperative pancreatic fistula formation after pancreaticoduodenectomy","volume":"20","author":"Nishida","year":"2016","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.pan.2021.03.002_bib16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/2050640618781188","article-title":"Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment","volume":"6","author":"Antonelli","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.pan.2021.03.002_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pan.2014.11.006","article-title":"Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review","volume":"15","author":"Ozola Zalite","year":"2015","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2021.03.002_bib18","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/hepr.12774","article-title":"Japan society of hepatology guidelines for sarcopenia in liver disease (1st edition): recommendation from the working group for creation of sarcopenia assessment criteria","volume":"46","author":"Nishikawa","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.pan.2021.03.002_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pan.2018.11.001","article-title":"Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving folfirinox chemotherapy","volume":"19","author":"Kurita","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2021.03.002_bib20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.pan.2021.03.002_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-11-1","article-title":"Application of weibull model for survival of patients with gastric cancer","volume":"11","author":"Zhu","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.pan.2021.03.002_bib22","first-page":"11","article-title":"Survival analysis of colorectal cancer patients using exponentiated weibull distribution","author":"Yoosefi","year":"2018","journal-title":"International Journal of Cancer Management"},{"key":"10.1016\/j.pan.2021.03.002_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/cancers13030427","article-title":"Cancer treatment-induced accelerated aging in cancer survivors: biology and assessment","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.pan.2021.03.002_bib24","first-page":"11","article-title":"The challenge by multiple environmental and biological factors induce inflammation in aging: their role in the promotion of chronic disease","author":"Bachmann","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.pan.2021.03.002_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2522\/ptj.20120127","article-title":"Evaluative frailty index for physical activity (efip): a reliable and valid instrument to measure changes in level of frailty","volume":"93","author":"De Vries","year":"2013","journal-title":"Phys Ther"},{"key":"10.1016\/j.pan.2021.03.002_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/ajcn\/83.5.1142","article-title":"Frailty syndrome and skeletal muscle: results from the invecchiare in chianti study","volume":"83","author":"Cesari","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pan.2021.03.002_bib27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00432-012-1371-3","article-title":"Prognostic value of ca 19-9, cea, crp, ldh and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy","volume":"139","author":"Haas","year":"2013","journal-title":"J\u00a0Canc Res Clin Oncol"},{"key":"10.1016\/j.pan.2021.03.002_bib28","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.pan.2018.07.007","article-title":"Protocol digest of randomized phase ii study of modified folfirinox versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan clinical oncology group study (jcog1407)","volume":"18","author":"Mizusawa","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2021.03.002_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","article-title":"Adjuvant chemotherapy of s-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (jaspac 01)","volume":"388","author":"Uesaka","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pan.2021.03.002_bib30","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pan.2021.03.002_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2018.04.023","article-title":"Platelet-to-lymphocyte ratio in advanced cancer: review and meta-analysis","volume":"483","author":"Li","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pan.2021.03.002_bib32","series-title":"National cancer institute common terminology criteria for adverse events (ctcae), version 5.0","author":"services Udohh","year":"2017"},{"key":"10.1016\/j.pan.2021.03.002_bib33","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.4143\/crt.2015.250","article-title":"Prognostic factors for risk stratification of patients with recurrent or metastatic pancreatic adenocarcinoma who were treated with gemcitabine-based chemotherapy","volume":"48","author":"Park","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.pan.2021.03.002_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1985","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.pan.2021.03.002_bib35","first-page":"570","article-title":"Measuring visceral adipose tissue content from contrast enhanced computed tomography","volume":"20","author":"Vehmas","year":"1996","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pan.2021.03.002_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.sla.0000236600.24667.a4","article-title":"Outcomes of adult-to-adult living donor liver transplantation: a single institution\u2019s experience with 335 consecutive cases","volume":"245","author":"Morioka","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2021.03.002_bib37","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2021.03.002_bib38","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00330-015-3963-1","article-title":"Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer","volume":"26","author":"Tamandl","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.pan.2021.03.002_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pan.2021.03.002_bib40","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.4143\/crt.2015.250","article-title":"Prognostic factors for risk stratification of patients with recurrent or metastatic pancreatic adenocarcinoma who were treated with gemcitabine-based chemotherapy","volume":"48","author":"Park","year":"2016","journal-title":"Cancer Research and Treatment"},{"key":"10.1016\/j.pan.2021.03.002_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.metabol.2017.09.005","article-title":"Carnitine induces autophagy and restores high-fat diet-induced mitochondrial dysfunction","volume":"78","author":"Choi","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.pan.2021.03.002_bib42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10985-017-9394-3","article-title":"Exponentiated weibull regression for time-to-event data","volume":"24","author":"Khan","year":"2018","journal-title":"Lifetime Data Anal"},{"key":"10.1016\/j.pan.2021.03.002_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cmpb.2013.07.021","article-title":"Mixture and non-mixture cure fraction models based on the generalized modified weibull distribution with an application to gastric cancer data","volume":"112","author":"Martinez","year":"2013","journal-title":"Comput Methods Progr Biomed"},{"key":"10.1016\/j.pan.2021.03.002_bib44","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"New look at the statistical model identification","volume":"19","author":"H","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"key":"10.1016\/j.pan.2021.03.002_bib45","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s11605-018-3972-x","article-title":"A\u00a0preoperative prognostic scoring system to predict prognosis for resectable pancreatic cancer: who will benefit from upfront surgery?","volume":"23","author":"Nakamura","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.pan.2021.03.002_bib46","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2021.03.002_bib47","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"Folfirinox versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2021.03.002_bib48","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1200\/JCO.2018.78.9636","article-title":"Metastatic pancreatic cancer: asco clinical practice guideline update","volume":"36","author":"Sohal","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2021.03.002_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","article-title":"International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017","volume":"18","author":"Isaji","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2021.03.002_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12876-019-0975-3","article-title":"Tumor location as an indicator of survival in t1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis","volume":"19","author":"Meng","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.pan.2021.03.002_bib51","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1080\/0284186X.2018.1518593","article-title":"Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis","volume":"57","author":"van Erning","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.pan.2021.03.002_bib52","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1002\/bjs.10772","article-title":"Australian Pancreatic Cancer Genome I, et\u00a0al. Defining the molecular pathology of pancreatic body and tail adenocarcinoma","volume":"105","author":"Dreyer","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.pan.2021.03.002_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/IJGC:32:1:35","article-title":"Pretreatment ca 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine","volume":"32","author":"Saad","year":"2002","journal-title":"Int J Gastrointest Canc"},{"key":"10.1016\/j.pan.2021.03.002_bib54","first-page":"673","article-title":"Cea and ca-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis","volume":"21","author":"Tsavaris","year":"2009","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.pan.2021.03.002_bib55","first-page":"360","article-title":"Pancreas adenocarcinoma: ascites, clinical manifestations, and management implications","volume":"15","author":"Hicks","year":"2016","journal-title":"Clin Colorectal Canc"},{"key":"10.1016\/j.pan.2021.03.002_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-5101-3","article-title":"Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the anice-pac study","volume":"18","author":"Fern\u00e1ndez","year":"2018","journal-title":"BMC Canc"},{"key":"10.1016\/j.pan.2021.03.002_bib57","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3390\/cancers11121861","article-title":"Cachexia and sarcopenia in older adults with cancer: a comprehensive review","volume":"11","author":"Dunne","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.pan.2021.03.002_bib58","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.12998\/wjcc.v8.i7.1188","article-title":"Sarcopenia in patients with colorectal cancer: a comprehensive review","volume":"8","author":"Vergara-Fernandez","year":"2020","journal-title":"World Journal of Clinical Cases"},{"key":"10.1016\/j.pan.2021.03.002_bib59","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the european working group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.pan.2021.03.002_bib60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in asia: consensus report of the asian working group for sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.pan.2021.03.002_bib61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.pan.2021.03.002_bib62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12029-018-0116-1","article-title":"Efficacy of docetaxel and oxaliplatin regimen as a second-line therapy for patients with advanced pancreatic adenocarcinoma","volume":"50","author":"Rayan","year":"2019","journal-title":"J\u00a0Gastrointest Canc"},{"issue":"1","key":"10.1016\/j.pan.2021.03.002_bib63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jgo.2020.07.004","article-title":"Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancreatic cancer receiving first-line palliative chemotherapy","volume":"12","author":"Rittberg","year":"2021","journal-title":"J\u00a0Geriatr Oncol"},{"key":"10.1016\/j.pan.2021.03.002_bib64","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1061::AID-CNCR1>3.0.CO;2-B","article-title":"The concept of tenju-gann, or \"natural-end cancer","volume":"83","author":"Kitagawa","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2021.03.002_bib65","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12885-018-4439-x","article-title":"Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis","volume":"18","author":"Dominguez-Munoz","year":"2018","journal-title":"BMC Canc"},{"key":"10.1016\/j.pan.2021.03.002_bib66","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-018-0235-7","article-title":"Altered exocrine function can drive adipose wasting in early pancreatic cancer","volume":"558","author":"Danai","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pan.2021.03.002_bib67","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.trecan.2018.10.001","article-title":"Cancer cachexia: more than skeletal muscle wasting","volume":"4","author":"Schmidt","year":"2018","journal-title":"Trends Cancer"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390321000958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390321000958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:14:16Z","timestamp":1761408856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390321000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1424390321000958"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2021.03.002","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2021.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 IAP and EPC. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}